Cancerous inhibitor of PP2A (CIP2A)—also known as KIAA1524 or p90 tumor-associated antigen—is a human oncoprotein that is overexpressed in human neck and head carcinomas as well as breast, colon, and gastric cancers [5, 9–12]. Here, CIP2A is linked to gastric cancer.